SimSimi

What SimSimi does

SimSimi Inc. is a Seoul-based conversational AI company founded in 2003 by CEO Choi Jung-hoi after developing the SimSimi chatbot in 2002. The company operates a multi-product AI platform anchored by its flagship SimSimi chatbot, which has accumulated 450 million cumulative users across 111 languages and is supported by a proprietary dialogue engine (AICR) and a deep-learning-based malicious dialogue detection system (DBSC) with a Korean F1 score above 0.97. SimSimi generates revenue through four primary streams: a freemium consumer chatbot app with in-app purchases, usage-based API access via SimSimi Workshop Services (serving 30,000+ developers since 2012, including Baidu and Sanrio Digital), B2B/B2G subscriptions for the ChatBrain generative AI productivity solution (adopted by Korean municipalities including Gyeongsangbuk-do, Yeongju City, and Yeongcheon City), and emerging healthcare and accessibility applications including Dr. SimSimi (digital therapeutics for depression) and the Free Wings AI mobility device.

The company's go-to-market combines product-led growth for consumer products with direct sales for government and enterprise accounts. Distribution channels include global app stores, web, an API platform for developers, and direct B2G sales to Korean local governments. SimSimi has expanded its technology stack beyond text to include computer vision (monocular depth estimation for accessibility), video Q&A within ChatBrain, and generative AI integrations, while pursuing on-premises enterprise deployments via Factory SimSimi. The company has secured multiple Korean government certifications (GS Grade 1 for AI dialogue data construction, TI-3 technical credit evaluation, AI reliability certification in progress via TTA, and Smart Factory Level 2), won the 2024 Minister of Science and ICT Award, and formed a consortium with FakeEyes and DIVE XR for the CES 2026 launch of the Free Wings platform. SimSimi remains privately held with no external funding rounds disclosed, operating with a headcount in the 11-50 range.

Name

SimSimi

Legal name

심심이주식회사 SimSimi Inc.

Website

https://simsimi.kr

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

SimSimi Inc. is a Seoul-based conversational AI company operating the SimSimi chatbot (450M cumulative users, 111 languages), ChatBrain generative AI for government, DBSC toxicity detection, and developer APIs serving 30,000+ developers globally since 2012.

Ownership category

akta.pro rank

Product category

Conversational AI Platform

NAICS

Custom Computer Programming Services (541511), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming Services (7371), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Conversational AI Platforms (chat/voice bots, orchestration) (HDAAAFAC)

akta.pro secondary industry

Workplace Automation & Self-Service (RPA for IT, Chatbots, Virtual Agents) (BPAEAIAI)

Keywords

• Conversational AI platform
• AI chatbot services
• Content moderation AI
• Generative AI solutions
• AI developer APIs

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. SimSimi App (Consumer): Freemium model for the SimSimi chatbot app available on iOS, Android, and web. Generates revenue through in-app purchases, premium features, and advertising within the app. Established revenue model since 2004 SMS service.
2. SimSimi Workshop API Services: API access to AI conversation engine (AICR) and malicious dialogue detection (DBSC) for developers and enterprises. Served over 30,000 developers since 2012 including major clients like Baidu and Sanrio Digital. Revenue from usage-based API calls and licensing fees.
3. ChatBrain Enterprise/Government Solutions: B2B/B2G generative AI solutions for productivity enhancement. Adopted by government agencies including Gyeongsangbuk-do, Yeongju City, and Yeongcheon City. On-premise solutions like Factory SimSimi available for enterprises. Revenue from software licenses, subscriptions, and professional services.
4. Healthcare Digital Therapeutics: Doctor SimSimi depression treatment app developed in collaboration with healthcare institutions. Potential revenue from clinical partnerships and healthcare integration.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels9 records

Core offering

SimSimi develops and operates AI conversational products including the SimSimi multilingual chatbot app for consumers, ChatBrain generative AI productivity solution for enterprises and government agencies, DBSC malicious dialogue detection neural network for content moderation, and SimSimi Workshop Services providing AICR conversation engine and DBSC APIs to third-party developers. The company has accumulated 450 million cumulative users across 111 languages and serves 30,000+ developers globally.

Product overview

SimSimi Inc. operates a platform-plus-modules architecture centered on its flagship AI chatbot SimSimi, enhanced by specialized AI solutions. The core SimSimi chatbot (2002) handles conversational AI across 111 languages with 450M users. ChatBrain (2023) extends into B2B/B2G generative AI for workplace productivity. DBSC provides content moderation. SimSimi Workshop Services offers developer APIs. Dr. SimSimi targets mental health. Factory SimSimi serves enterprise on-premise needs. SensorBrain enables digital persona management. The company is expanding into XR/generative AI training systems and accessibility solutions.

Differentiator

Problem solved

Functional benefit

Brands

• ChatBrain (챗브레인): Generative AI-based work productivity improvement solution, launched in March 2023 as first ChatGPT API application. Adopted by local government agencies for administrative tasks.
• DBSC (악성 대화 탐지 신경망)
• SimSimi Workshop Services (심심이 챗봇공방)
• Dr. SimSimi (닥터 심심이)

Products and services

• SimSimi Chatbot AI social chatbot for entertainment, companionship, and conversation across 111 languages. Features a 'teaching' capability allowing users to train responses with single sentences. Has 450 million cumulative users and 30+ million users have taught it to talk.
• ChatBrain Generative AI-based work productivity solution for government agencies and enterprises. Provides official document drafting, business proposal writing, and video Q&A modules. First generative AI solution officially adopted for local government administrative work in Korea.
• DBSC (Deep Bad Conversation Screening) Neural network model for detecting toxic or malicious content in conversations across multiple languages. Korean F1 score of 0.97+. Applied to online comments, gaming, broadcasting, dating, and social network services for content safety.
• SimSimi Workshop Services Developer platform providing chatbot development modules and APIs including AICR conversation engine and DBSC toxicity detection. Used by over 30,000 developers globally including Baidu and Sanrio Digital.
• Dr. SimSimi

Quantifiable outcome

• 29% empathetic response rate compared to ChatGPT (4.8%) and Alexa (11.8%) in depression help-seeking queries
• +5 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and major.

• FakeEyescoreStrategic or Co-development Partner · 1 January 2026Three-company consortium for developing walking assistance platform for visually impaired using vision AI technology. FakeEyes specializes in vision AI and extended reality. The platform uses monocular depth estimation and semantic segmentation for real-time obstacle detection and navigation, operating entirely offline. Target unveiling at CES 2026 with global launch planned for Q1 2026.
• DIVE XRcoreStrategic or Co-development Partner · 1 January 2026Three-company consortium partner for developing walking assistance platform for visually impaired. DIVE XR contributes extended reality expertise to the partnership with SimSimi Inc. and FakeEyes for the Free Wings accessibility technology.
• Global Big Tech Company S (글로벌 빅테크 S사)majorStrategic or Co-development Partner · 1 January 2026Partnership for developing XR + generative AI-based virtual human real-time conversation training/evaluation system. Development announced for 2026. The identity of Company S is not disclosed in available sources.
• Korea Radio Promotion Association (한국전파진흥협회)majorStrategic or Co-development Partner · 1 January 2024Government support partner for generative AI-based visual impairment self-navigation assistance system development started in 2024. Association provides funding and institutional support for accessibility technology research.
• Korea Health Industry Development Institute (보건산업진흥원)majorStrategic or Co-development Partner · 1 January 2023Healthcare institution partnership for developing Doctor SimSimi, an AI conversation-based depression digital treatment clinical app. The app is a result of government-supported healthcare AI initiative.
• Korea University Anam Hospital (고려대학교 안암병원)majorStrategic or Co-development Partner · 1 January 2023Clinical partner led by Professor Ham Byung-ju for developing Doctor SimSimi depression treatment app. Hospital provides medical expertise and clinical validation for the digital therapeutics application.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Naver (HyperCLOVA X): Naver is a broad Korean incumbent developing its own foundation model (HyperCLOVA X) and offering enterprise/government GenAI services. It is comparable as a Korean-language GenAI competitor for the same municipal, education, and enterprise customers SimSimi serves with ChatBrain.
• Microsoft Copilot: Microsoft Copilot is a broad incumbent enterprise GenAI productivity suite that competes directly with SimSimi's ChatBrain in workplace document drafting, summarization, and Q&A. It also serves as a downstream alternative to ChatBrain for Korean enterprise and government customers.
• Kakao (Kakao Brain, Kanana): Kakao is a broad Korean incumbent with its own foundation model (Kanana) and enterprise AI offerings targeting Korean enterprises and government. It competes with ChatBrain for the same Korean B2B/B2G conversational AI procurement and shares SimSimi's Korean-language data advantage.

Emerging players

• Woebot Health: Woebot Health is an emerging AI mental-health chatbot comparable to Dr. SimSimi. Both deliver clinically-informed conversational therapy experiences, pursue regulatory and clinical validation pathways, and target payers and healthcare providers rather than purely consumer markets.
• Wysa: Wysa is an emerging AI mental-health chatbot peer comparable to SimSimi's Dr. SimSimi digital therapeutic. Both target emotional support and depression/anxiety use cases via conversational AI and pursue healthcare-provider and reimbursement partnerships, making them direct comparables in the AI-driven digital therapeutics space.
• SightCall (and other accessibility AI platforms): SightCall and similar visual-assistance AI platforms are emerging peers comparable to SimSimi's Free Wings walking-assistance device for visually impaired users. Both apply computer vision (depth estimation, obstacle detection) and voice interaction for real-time accessibility navigation.

Direct peers

• Replika: Replika is a direct peer in the AI companion chatbot category, targeting emotional-support and conversational use cases globally. Both SimSimi and Replika monetize consumer chat via freemium/IAP and compete for users seeking empathetic AI conversation, particularly validated by SimSimi's reported 29% empathetic-response benchmark advantage.
• Pandorabots: Pandorabots is a direct peer in the conversational AI platform/chatbot development space. Both expose chatbot engines and developer APIs (SimSimi Workshop Services vs Pandorabots Playground/MIT-licensed stacks) to third-party developers and enterprises building custom conversational applications.
• Character.AI: Character.AI is a direct conversational AI peer, offering consumer-facing AI character/companion chat experiences similar to SimSimi's chatbot. Both rely on user-driven conversation, brand-led consumer acquisition, and freemium monetization, competing for the same global conversational AI audience.

Others

• OpenAI (ChatGPT Enterprise / ChatGPT): OpenAI is both the underlying model provider for ChatBrain and a broader market competitor across consumer chat (ChatGPT) and enterprise GenAI. SimSimi's ChatBrain roadmap is directly coupled to OpenAI's API strategy, while ChatGPT competes with SimSimi's consumer chatbot at the product level.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/SimSimiInc
• GitHubgithub.com/simsimi
• LinkedInlinkedin.com/company/simsimi-inc
• Instagraminstagram.com/hey_simsimi

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SimSimi